236 related articles for article (PubMed ID: 31301589)
1. Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study.
Attilakos A; Dinopoulos A; Tsirouda M; Paschalidou M; Prasouli A; Stamati A; Parasxou N; Garoufi A
Epilepsy Res; 2019 Sep; 155():106162. PubMed ID: 31301589
[TBL] [Abstract][Full Text] [Related]
2. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K
Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483
[TBL] [Abstract][Full Text] [Related]
3. Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study.
Garoufi A; Koemtzidou E; Katsarou E; Dinopoulos A; Kalimeraki I; Fotinou A; Drakatos A; Attilakos A
Eur J Neurol; 2014; 21(1):118-23. PubMed ID: 24118208
[TBL] [Abstract][Full Text] [Related]
4. The effect of levetiracetam and oxcarbazepine monotherapy on thyroid hormones and bone metabolism in children with epilepsy: A prospective study.
Shi KL; Guo JX; Zhao HM; Hong H; Yang CZ; Wu YH; Du LJ
Epilepsy Behav; 2020 Dec; 113():107555. PubMed ID: 33242769
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: A prospective study.
Attilakos A; Dinopoulos A; Paschalidou M; Tsirouda M; Karalexi M; Prasouli A; Garoufi A
Epilepsy Res; 2018 Sep; 145():160-162. PubMed ID: 30007241
[TBL] [Abstract][Full Text] [Related]
6. Short-Term and Long-Term Effects of Levetiracetam Monotherapy on Homocysteine Metabolism in Children with Epilepsy: A Prospective Study.
Attilakos A; Paschalidou M; Garoufi A; Tsirouda M; Papadopoulou A; Karalexi M; Dinopoulos A
J Clin Neurol; 2019 Apr; 15(2):149-151. PubMed ID: 30938107
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
8. The effect of antiepileptic drugs on thyroid function in children.
Yılmaz U; Yılmaz TS; Akıncı G; Korkmaz HA; Tekgül H
Seizure; 2014 Jan; 23(1):29-35. PubMed ID: 24091037
[TBL] [Abstract][Full Text] [Related]
9. Short-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: a prospective study.
Dinopoulos A; Attilakos A; Paschalidou M; Tsirouda M; Garoufi A; Moustaki M; Siafakas N; Papaevangelou V
Epilepsy Res; 2014 May; 108(4):820-3. PubMed ID: 24630047
[TBL] [Abstract][Full Text] [Related]
10. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.
Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F
Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332
[TBL] [Abstract][Full Text] [Related]
11. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M
Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
[TBL] [Abstract][Full Text] [Related]
12. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Kim DW; Lee SY; Shon YM; Kim JH
Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
[TBL] [Abstract][Full Text] [Related]
13. Serum lipid profile in children receiving anti-epileptic drug monotherapy: is it atherogenic?
Tekgul H; Demir N; Gokben S
J Pediatr Endocrinol Metab; 2006 Sep; 19(9):1151-5. PubMed ID: 17128563
[TBL] [Abstract][Full Text] [Related]
14. Effect of Levetiracetam Monotherapy in Nonlesional Focal Childhood Epilepsy.
Kanemura H; Sano F; Ohyama T; Sugita K; Aihara M
Neuropediatrics; 2018 Apr; 49(2):135-141. PubMed ID: 29253909
[TBL] [Abstract][Full Text] [Related]
15. Serum thyroid hormone balance and lipid profile in patients with epilepsy.
Hamed SA; Hamed EA; Kandil MR; El-Shereef HK; Abdellah MM; Omar H
Epilepsy Res; 2005; 66(1-3):173-83. PubMed ID: 16169189
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy.
Eirís JM; Lojo S; Del Río MC; Novo I; Bravo M; Pavón P; Castro-Gago M
Neurology; 1995 Jun; 45(6):1155-7. PubMed ID: 7783881
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam monotherapy in children with epilepsy: Experience from a tertiary pediatric neurology center.
Yıldırım M; Bektaş Ö; Akıncı Göktaş Ö; Yüksel MF; Şahin S; Tıraş Teber S
Epilepsy Behav; 2021 Mar; 116():107745. PubMed ID: 33508749
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 2003 Dec; 25(6):690-9. PubMed ID: 14639055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
